• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MYX
Click for more information
11.2% $4.38

MAYNE PHARMA GROUP LIMITED

Market Cap $372.6M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MYX
What MYX chart shouts
3 4 5
15:47 271 81K
15:47 Last post  ydqcau Comments Created with Sketch.  271  Views Created with Sketch.  81K 
MYX
Ann: 2024 Full Year Results Media Release 		23/08/24 15 3.8K
23/08/24 Last post  joca Comments Created with Sketch.  15  Views Created with Sketch.  3.8K 
MYX
Ann: 2024 Full Year Results Investor Presentation 		23/08/24 0 291
23/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  291 
MYX
Ann: Appendix 4E and Full Year Statutory Accounts 		23/08/24 0 196
23/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  196 
MYX
Ann: MYX announces patent lawsuit against Sun Pharmaceutical 		19/08/24 19 6.1K
19/08/24 Last post  roboshan Comments Created with Sketch.  19  Views Created with Sketch.  6.1K 
MYX
Ann: Notification of date for release of FY24 results 		16/08/24 2 782
16/08/24 Last post  stephencca Comments Created with Sketch.  2  Views Created with Sketch.  782 
MYX
Ann: Class action settlement
2
01/08/24 108 37K
01/08/24 Last post  KamikazePilot Comments Created with Sketch.  108  Views Created with Sketch.  37K 
MYX
News: MYX Mayne Pharma Announces Patent Lawsuit Against Sun Pharmaceutical 		25/07/24 0 213
25/07/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  213 

See All Discussions arrow Created with Sketch.

Timeline

2024 Full Year Results Investor Presentation
23 Aug 08:48
 
2024 Full Year Results Media Release
23 Aug 08:47
 
Appendix 4E and Full Year Statutory Accounts
23 Aug 08:44
 
Notification of date for release of FY24 results
15 Aug 16:34
 
MYX announces patent lawsuit against Sun Pharmaceutical
25 Jul 09:32
 
Class action settlement
02 Jul 08:28
 
View More arrow Created with Sketch.

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
(20min delay)
Last
$4.38 		Change
0.440(11.2%) 		Mkt cap ! $372.6M
Open High Low Value Volume
$4.40 $4.79 $4.18 $2.649M 590.1K

Buyers (Bids)

No. Vol. Price($)
1 1271 $4.35
 

Sellers (Offers)

Price($) Vol. No.
$4.44 1271 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
$4.38 		  Change
0.440 ( 11.0 %)
Open High Low Volume
$4.42 $4.79 $4.21 26856
Last updated 15.59pm 23/08/2024 ?
MYX (ASX) Chart

Top Stories

Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions

Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
The business of sport: Warren Tredrea's take on this week's news Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings A southward cluster of outcropping pegmatites on-site Chariot Corporation's (ASX:CC9) flagship Black Mountain hard rock lithium project has led management and geotechs to sign off on a promising future drilling target for the company as exploration on-site gathers pace.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
NEWS How institutional adoption is shaping the future of crypto
right-arrow Created with Sketch.
RDN Raiden Resources hopeful it can start drilling Andover South, WA, as early as mid-October
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.